USFDA Inspects Dr Reddy's Hyderabad R'D Facility
Dr Reddy's Laboratories confirms USFDA inspection of its Hyderabad R'D facility. The outcome of the inspection will be disclosed to stock exchanges.
New Delhi, Dec 7 (PTI) Dr Reddy's Laboratories on Thursday said the US health regulator is conducting an inspection of its Hyderabad-based R&D facility.
"We would like to inform you that the US Food and Drug Administration (USFDA) has commenced an inspection at our R&D facility in Bachupally, Hyderabad, and the outcome of the same will be updated and necessary disclosure will be made with the stock exchanges," it said in a regulatory filing.
The company proactively discloses the outcome of every USFDA inspection to the stock exchanges immediately after the end of the inspection, it added.
Shares of the company were trading 1.2 per cent up at Rs 5,796.40 apiece on the BSE.
"We would like to inform you that the US Food and Drug Administration (USFDA) has commenced an inspection at our R&D facility in Bachupally, Hyderabad, and the outcome of the same will be updated and necessary disclosure will be made with the stock exchanges," it said in a regulatory filing.
The company proactively discloses the outcome of every USFDA inspection to the stock exchanges immediately after the end of the inspection, it added.
Shares of the company were trading 1.2 per cent up at Rs 5,796.40 apiece on the BSE.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Sylph-Industries
- 0.87 (+ 4.82)
- 31834236
- Spicejet
- 14.73 (+ 7.83)
- 23777843
- Alstone-Textiles
- 0.15 (+ 7.14)
- 20242331
- Standard-Cap-Mkt
- 0.59 (+ 9.26)
- 19404745
- Supha-Pharmachem
- 0.45 (+ 4.65)
- 15568139
MORE NEWS
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback